Becton Dickinson and Co. (BDX) Stake Decreased by Baker Ellis Asset Management LLC
Baker Ellis Asset Management LLC lowered its position in Becton Dickinson and Co. (NYSE:BDX) by 0.8% during the second quarter, Holdings Channel reports. The institutional investor owned 950 shares of the company’s stock after selling 8 shares during the period. Baker Ellis Asset Management LLC’s holdings in Becton Dickinson and were worth $161,000 at the end of the most recent quarter.
A number of other hedge funds also recently added to or reduced their stakes in the company. ClariVest Asset Management LLC bought a new stake in Becton Dickinson and during the second quarter worth approximately $170,000. LMR Partners LLP bought a new stake in Becton Dickinson and during the second quarter worth approximately $1,571,000. Trillium Asset Management LLC increased its stake in Becton Dickinson and by 1.1% in the second quarter. Trillium Asset Management LLC now owns 27,787 shares of the company’s stock worth $4,712,000 after buying an additional 312 shares in the last quarter. Huntington National Bank increased its stake in Becton Dickinson and by 181.7% in the second quarter. Huntington National Bank now owns 133,893 shares of the company’s stock worth $22,707,000 after buying an additional 86,365 shares in the last quarter. Finally, First National Trust Co. increased its stake in Becton Dickinson and by 15.8% in the second quarter. First National Trust Co. now owns 1,704 shares of the company’s stock worth $289,000 after buying an additional 233 shares in the last quarter. 81.96% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Becton Dickinson and Co. (NYSE:BDX) traded up 0.16% during trading on Friday, reaching $177.40. 617,071 shares of the company traded hands. The firm has a 50-day moving average price of $176.38 and a 200-day moving average price of $168.90. Becton Dickinson and Co. has a 12 month low of $129.50 and a 12 month high of $181.76. The firm has a market capitalization of $37.77 billion, a PE ratio of 33.85 and a beta of 0.93.
Becton Dickinson and (NYSE:BDX) last announced its earnings results on Thursday, August 4th. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $2.21 by $0.14. Becton Dickinson and had a net margin of 9.24% and a return on equity of 24.26%. The company earned $3.20 billion during the quarter, compared to analysts’ expectations of $3.21 billion. During the same period last year, the company posted $2.05 earnings per share. The business’s revenue for the quarter was up 2.5% on a year-over-year basis. Equities research analysts anticipate that Becton Dickinson and Co. will post $8.56 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Friday, September 30th. Shareholders of record on Friday, September 9th were issued a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 1.49%. The ex-dividend date was Wednesday, September 7th. Becton Dickinson and’s payout ratio is 50.19%.
Several brokerages have issued reports on BDX. Citigroup Inc. downgraded shares of Becton Dickinson and from a “neutral” rating to a “sell” rating and reduced their price target for the company from $167.00 to $165.00 in a report on Friday, September 23rd. Cowen and Company reaffirmed an “outperform” rating and issued a $185.00 price target on shares of Becton Dickinson and in a report on Tuesday, August 16th. Leerink Swann reaffirmed a “hold” rating on shares of Becton Dickinson and in a report on Tuesday, August 9th. Jefferies Group reaffirmed a “buy” rating on shares of Becton Dickinson and in a report on Friday, August 5th. Finally, Zacks Investment Research downgraded shares of Becton Dickinson and from a “buy” rating to a “hold” rating in a report on Wednesday, July 13th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $170.82.
In other news, insider Gary M. Cohen sold 29,367 shares of the stock in a transaction that occurred on Thursday, August 11th. The shares were sold at an average price of $176.81, for a total value of $5,192,379.27. Following the completion of the sale, the insider now directly owns 125,870 shares of the company’s stock, valued at $22,255,074.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Linda M. Tharby sold 11,704 shares of the stock in a transaction that occurred on Tuesday, September 6th. The stock was sold at an average price of $177.27, for a total transaction of $2,074,768.08. Following the completion of the sale, the insider now directly owns 22,146 shares of the company’s stock, valued at $3,925,821.42. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.
About Becton Dickinson and
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co. (NYSE:BDX).
Receive News & Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related companies with MarketBeat.com's FREE daily email newsletter.